Latest Expert Opinions

Signal
Opinion
Expert
BUY WEAKNESS
BUY WEAKNESS
February 21, 2012
Recently reported a really lousy quarter but even so, the stock went up. Very complicated company to follow. Just because corn prices and fertilizers are going higher, doesn't mean they are making more or less money. You have to look at this one on a yearly basis. Cheap on valuation and a great raiser of dividends. Try to get under $30.
Show full opinionHide full opinion
Recently reported a really lousy quarter but even so, the stock went up. Very complicated company to follow. Just because corn prices and fertilizers are going higher, doesn't mean they are making more or less money. You have to look at this one on a yearly basis. Cheap on valuation and a great raiser of dividends. Try to get under $30.
BUY
BUY
February 21, 2012
Canada had a good trade mission with China and it looks like they are more open to uranium exports. This has to be positive for this company. Earnings are steadily improving. Uranium price has nowhere to go but higher. The wildcard is Russia running out of nuclear material from their weapons.
Show full opinionHide full opinion
Cameco Corporation (CCO-T)
February 21, 2012
Canada had a good trade mission with China and it looks like they are more open to uranium exports. This has to be positive for this company. Earnings are steadily improving. Uranium price has nowhere to go but higher. The wildcard is Russia running out of nuclear material from their weapons.
BUY
BUY
February 21, 2012
Every Canadian should have exposure to health care and it is very hard to get this in Canada. Not his favourite name but you can’t go too far wrong. Earnings are finally recovering. Good dividend growth. There is a lack of new drugs, but they will come, over time.
Show full opinionHide full opinion
Merck & Company (MRK-N)
February 21, 2012
Every Canadian should have exposure to health care and it is very hard to get this in Canada. Not his favourite name but you can’t go too far wrong. Earnings are finally recovering. Good dividend growth. There is a lack of new drugs, but they will come, over time.
DON'T BUY
DON'T BUY
February 21, 2012
Terrific company. Raised their guidance to $2.50. Problem is valuation. Has gotten ahead of itself.
Show full opinionHide full opinion
Home Depot (HD-N)
February 21, 2012
Terrific company. Raised their guidance to $2.50. Problem is valuation. Has gotten ahead of itself.
BUY
BUY
February 21, 2012
(Market Call Minute.) Raising dividends and cash flow is tremendous. Hated by the street, but buy for the long-term.
Show full opinionHide full opinion
(Market Call Minute.) Raising dividends and cash flow is tremendous. Hated by the street, but buy for the long-term.
DON'T BUY
DON'T BUY
February 21, 2012
(Market Call Minute.) Unbelievable company but evaluation is too high.
Show full opinionHide full opinion
Visa Inc. (V-N)
February 21, 2012
(Market Call Minute.) Unbelievable company but evaluation is too high.
DON'T BUY
DON'T BUY
February 21, 2012
(Market Call Minute.) Great company but Warren Buffett has been trimming his position so he guesses you shouldn't Buy.
Show full opinionHide full opinion
Johnson & Johnson (JNJ-N)
February 21, 2012
(Market Call Minute.) Great company but Warren Buffett has been trimming his position so he guesses you shouldn't Buy.